Immunocore Holdings annual capital expenditures (capex)
2021
2022
2023
2024
2025
Immunocore Holdings Capital Expenditures (CapEx) Growth & History (IMCR)
Immunocore Holdings's capital expenditures (capex) was $4.3M for fiscal 2025.
View full Immunocore Holdings company overviewImmunocore Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.3M | −$833,000 | −16.10% |
| 2024 | 2024-12-31 | $5.2M | −$252,000 | −4.65% |
| 2023 | 2023-12-31 | $5.4M | $3.2M | +146.26% |
| 2022 | 2022-12-31 | $2.2M | $817,000 | +58.95% |
| 2021 | 2021-12-31 | $1.4M | — | — |
Immunocore Holdings quarterly capital expenditures (capex)
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $786,000 | $372,000 | +89.86% |
| Q1 2026 | 2026-03-31 | $1.8M | $1.5M | +497.65% |
| Q4 2025 | 2025-12-31 | $2.9M | −$704,000 | −19.64% |
| Q3 2025 | 2025-09-30 | $748,000 | −$80,000 | −9.66% |
| Q2 2025 | 2025-06-30 | $414,000 | $83,000 | +25.08% |
| Q1 2025 | 2025-03-31 | $298,000 | −$132,000 | −30.70% |
| Q4 2024 | 2024-12-31 | $3.6M | $2.8M | +338.68% |
| Q3 2024 | 2024-09-30 | $828,000 | $616,000 | +290.57% |
| Q2 2024 | 2024-06-30 | $331,000 | −$1.1M | −76.27% |
| Q1 2024 | 2024-03-31 | $430,000 | −$2.6M | −85.67% |
| Q4 2023 | 2023-12-31 | $817,000 | — | — |
| Q3 2023 | 2023-09-30 | $212,000 | — | — |
| Q2 2023 | 2023-06-30 | $1.4M | — | — |
| Q1 2023 | 2023-03-31 | $3.0M | — | — |
Immunocore Holdings capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Immunocore Holdings's capital expenditures (capex) increased from $1.4M to $4.3M, a change of $3.0M. The latest reported quarter, Q2 2026, shows $786,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immunocore Holdings source filings ↗